Table 5 Frequencies of laboratory tests and patient monitoring visits per patient and model according to the Nigerian DR-TB guidelines

 GeneXpert

Test

1

–

1

–

1

–

 Sputum smear

Smear

1

–

1

–

1

–

 Culture – Liquid

Test

1

–

1

–

1

–

 1st and 2nd line DST - Solid culture

Test

1

–

1

–

1

–

 X-ray

Test

2

2

2

2

2

2

 ENT consultation

Consult

1

–

1

–

1

–

 Audiometry test

Test

9

–

9

–

9

–

 E, U, Cr

Test

8

–

8

–

8

–

 Thyroid function test

Test

2

2

2

2

2

2

 LFT

Test

3

4

3

4

3

4

 HIV Test

Test

1

–

1

–

1

–

 Pregnancy test

Test

0.5

–

0.5

–

0.5

–

 Pyrazinamide 400 mg

Tablet

972

1488

972

1488

972

1488

 Kanamycin 1 g vial

Vial

243

–

243

–

243

–

 Levofloxacin 250 mg

Caplet

729

1116

729

1116

729

1116

 Prothionamide 250 mg

Tablet

729

1116

729

1116

729

1116

 Cycloserine 250 mg

Capsule

729

1116

729

1116

729

1116

 Pyridoxine 10 mg

Tablet

729

1116

729

1116

729

1116

 Inpatient hospitalization days

Bed day

243

–

152

–

–

–

 Consultation at treatment center /Monthly clinic visit

Visit

–

12

3

12

8

12

 Visits to collect medication at DOT center/ DOT at DOT center

Visit

–

24

6

24

16

24

 Home visit - by DOT officer

Home visit

–

24

91

24

243

24

 Home visit by DR TB focal person

Home visit

–

12

3

12

8

12

 Home visit by TBL supervisor

Home visit

–

12

3

12

8

12

 Quarterly state team meeting

Meeting

–

4

1

4

3

4

 Quarterly state team home visit

Home visit

–

4

2

4

2

4

 Sputum smear

Smear

8

12

8

12

8

12

 Culture - Liquid

Test

8

6

8

6

8

6

 1st and 2nd line DST - Solid culture

Test

0.2^

0

0.2^

0

0.2^a

0